Physician profile
Dhaliah Eckert
NPI 1710142591
$545.68
in general payments reported to CMS, 2019-2025
9 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.20 · 2022: $81.71 · 2023: $139 · 2024: $57.38 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $173.94 | 2025 | Daxxify |
| Paratek Pharmaceuticals, INC. | $124.99 | 2023 | Nuzyra |
| Abbvie INC. | $92.55 | 2021-2025 | |
| Medtronic, INC. | $43.30 | 2022 | |
| Janssen Pharmaceuticals, INC | $34.40 | 2021-2023 | Xarelto |
| Gilead Sciences, INC. | $22.76 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.83 | 2022 | |
| Pfizer INC. | $17.58 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaliah Eckert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.